Table of Contents
- OTC HEALTHCARE IN ISRAEL : MARKET INSIGHT
- EXECUTIVE SUMMARY
- 2008 continues positive growth rates similar to the review period
- Demand for more specific treatments leads to new innovations and launches
- Private label benefits from unique market structure
- GSL revolution did not bring expected results
- Economic slowdown aside, some sectors are expected to see strong growth
- KEY TRENDS AND DEVELOPMENTS
- Unusual market structure with OTC drugs falling in the "health basket"
- Increased private label activity
- Specific drugs answer consumer demand for specification
- GSL revolution failed to impact the retail market as expected
- Economic slowdown is expected only in 2009
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services
2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- MARKET DATA
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: %
Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth
2008-2013
- APPENDIX
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication and Preventive Medicine
- Generics
- Switches
- Summary 1 OTC Healthcare Switches 2005-2007
- DEFINITIONS
- Summary 2 Research Sources
- LOCAL COMPANY PROFILES - ISRAEL
- DEXXON LTD - OTC HEALTHCARE - ISRAEL
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 3 Dexxon Ltd: Key Facts
- Summary 4 Dexxon Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 5 Dexxon Ltd: Competitive Position 2008
- NEW-PHARM DRUGSTORES LTD - OTC HEALTHCARE - ISRAEL
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 6 New-Pharm Drugstores Ltd: Key Facts
- Summary 7 New-Pharm Drugstores Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- REKAH PHARMACEUTICAL PRODUCTS LTD - OTC HEALTHCARE - ISRAEL
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 8 Rekah Pharmaceutical Products Ltd: Key Facts
- Summary 9 Rekah Pharmaceutical Products Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 10 Rekah Pharmaceutical Products Ltd: Competitive Position 2008
- SUPER-PHARM (ISRAEL) LTD - OTC HEALTHCARE - ISRAEL
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 11 Super Pharm Israel Ltd: Key Facts
- Summary 12 Super Pharm Israel Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- TEVA PHARMACEUTICAL INDUSTRIES LTD - OTC HEALTHCARE - ISRAEL
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 13 Teva Pharmaceutical Industries Ltd: Key Facts
- Summary 14 Teva Pharmaceutical Industries Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 15 Teva Pharmaceutical Industries Ltd: Competitive Position 2008
- TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD - OTC HEALTHCARE - ISRAEL
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 16 Trima Israel Pharmaceutical Products Maabarot Ltd: Key Facts
- Summary 17 Trima Israel Pharmaceutical Products Maabarot Ltd:
Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 18 Trima Israel Pharmaceutical Products Maabarot Ltd Competitive
Position 2008
- CALMING AND SLEEPING PRODUCTS IN ISRAEL
- HEADLINES
- SECTOR DATA
- Table 12 Sales of Calming and Sleeping Products: Value 2003-2008
- Table 13 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
- Table 14 Calming and Sleeping Products Company Shares by Value 2004-2008
- Table 15 Calming and Sleeping Products Brand Shares by Value 2005-2008
- Table 16 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
- Table 17 Forecast Sales of Calming and Sleeping Products: % Value Growth
2008-2013
|
Related Report
|